Dr. Ronald S. Go, MD

Dr. Go practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Go's NPI, 1891790515, was assigned on June 17, 2005. Dr. Go graduated from University of Santo Tomas in 1991. Dr. Go holds Minnesota license 39044.

Dr. Go's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Go's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Go is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Go to 4 more hospitals, 1 clinical lab and 1 hospice, each named with a free account. Dr. Go's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Go practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Go's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Go is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Go's licenses on file in 4 states: Minnesota, Arizona, Iowa and Wisconsin.

Dmand AI lists chronic anemia, chronic leukemia, lung cancer, lymphoma, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Go treats.

CMS data shows 331 Medicare services from Dr. Go across 12 procedure codes in 2024, for 245 Medicare patients. Medicare paid $24,539 for them.

CMS counts 245 Medicare patients who saw Dr. Go in 2024. The largest group is 65 to 74, with 108 patients. 71% of them have high blood pressure, and 65% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Go's median patient age at 67, with 53% women.

In 2024, Dr. Go wrote 130 Medicare Part D claims for 33 patients. 73% of them were for generic drugs. CMS names the drug for 39 of them, across 3 drugs with 11 or more claims each, at $178,691 in total drug cost. In 2023, CMS named 58 claims across 4 drugs.

Dr. Go accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Go as offering telehealth.

Dmand AI links 339 papers to Dr. Go, published from 2003 to 2025. 2017 was the busiest year, with 33. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Immunoglobulin Light-chain Amyloidosis. Dr. Go has published most often in Am J Hematol. Dr. Go's most frequent co-authors are Angela Dispenzieri, MD, Morie A. Gertz, MD and Shaji K. Kumar, MD.

Dmand AI links Dr. Go to 6 clinical trials, 2 of them phase 2 studies. Conditions studied include Thrombocytopenia, Hemoglobinuria, Paroxysmal and Melanoma. Carelon Research sponsors the most, 3. Open Payments lists research payments to Dr. Go that name 1 trial.

CMS Open Payments shows 5 general payments to Dr. Go from 3 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 60% of the total. Alexion Pharmaceuticals, Inc. paid the most, $973. It also lists 4 research payments totaling $36,750 in 2019, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Go, most recently CMS Stage 1 EHR in 2013.

Dr. Go graduated from University of Santo Tomas in 1991. Dr. Go is a member of ACP, ASCO and ASH.

Dr. Go is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.